Yiqi Liu is a Senior Investment Analyst at Exome, covering investment opportunities across all healthcare subsectors in the Greater China region. Prior to joining Exome in 2019, he interned in the investment banking divisions at BNP Paribas and Citi Orient Securities, where he actively participated in several M&A and IPO transactions in the Chinese capital market. Mr. Liu received a B.A. in Economics from Franklin & Marshall College and an M.A. in Economics from Columbia University.